ArticleTherapeutic advances in medical oncology2017

A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.

Daniel H Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.